Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousStem Cell TransplantationWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingCell DifferentiationHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesCell TransplantationKidney TransplantationHematopoiesisRecurrenceStem CellsCombined Modality TherapyRadiation ChimeraMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow ExaminationLeukemia, Myeloid, AcuteImmunosuppressive AgentsRemission InductionHematologic NeoplasmsTreatment OutcomeGraft RejectionEmbryonic Stem CellsHepatic Veno-Occlusive DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaBone RemodelingTime FactorsBone Marrow NeoplasmsTransplantation ImmunologyGraft vs Host ReactionLeukemia, MyeloidCell SeparationCells, CulturedInduced Pluripotent Stem CellsImmunosuppressionLymphocyte DepletionLeukocyte TransfusionLymphoma, Non-HodgkinHeart TransplantationAcute DiseaseSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssayT-LymphocytesHLA AntigensSurvival AnalysisMyelodysplastic SyndromesRetrospective StudiesLung TransplantationCell LineageCyclosporineActuarial AnalysisBone DensityHematologic DiseasesCell Culture TechniquesLymphocyte TransfusionNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsCarmustineOrgan TransplantationPancytopeniaGraft vs Tumor EffectGraft vs Leukemia EffectFollow-Up StudiesCytarabineLeukocyte CountSurvival RateCytomegalovirus InfectionsBone ResorptionSpleenGranulocyte Colony-Stimulating FactorPluripotent Stem CellsMelphalanMice, Inbred BALB CDisease-Free SurvivalEtoposideFlow CytometryLymphomaMultiple MyelomaFatal Outcome